Given that TXNDC12’s tumor-promoting effects are largely mediated through c-Myc, it is logical that depleting TXNDC12 leads to profound changes in tumor cell phenotypes both in vitro and in vivo. This evidence concerns the gene TXNDC12 and neoplasm.